This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Lars Dittus: Innovator in Antibody Research
Introduction
Lars Dittus is a notable inventor based in Ingelheim am Rhein, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies.
Latest Patents
Lars Dittus holds a patent titled "Antibodies to Connective Tissue Growth Factor (CTGF) and Uses Thereof." This patent reflects his innovative approach to addressing medical challenges through antibody research. He has 1 patent to his name.
Career Highlights
Lars Dittus is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work focuses on advancing therapeutic solutions that can improve patient outcomes.
Collaborations
Lars collaborates with various professionals in his field, including his coworker Andreas-David Brunner. Their combined expertise contributes to the innovative projects at Boehringer Ingelheim.
Conclusion
Lars Dittus is a dedicated inventor whose work in antibody research is paving the way for new medical advancements. His contributions are vital to the ongoing development of effective therapies.